Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mecobe is a vitamin B12 dietary supplement developed and manufactured by Myralis Indústria Farmacêutica Ltda. Its active ingredient is methylcobalamin (mecobalamina), a bioactive form of vitamin B12, provided at a dose of 1,000 mcg per sublingual tablet. Mecobe is indicated for the treatment of vitamin B12 deficiency, particularly in patients using metformin, and for general supplementation, including the management of hyperhomocysteinemia. The product functions by providing essential vitamin B12 for metabolic pathways necessary for red blood cell production, nerve function, and DNA synthesis. It is approved and available in Brazil as a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mecobe.